ENZO BIOCHEM (ENZB) SEC Filings

Enzo Biochem (ENZB): Schedule 13G/A filed by Beryl Capital entities shows no current stake. Beryl Capital Management LLC, Beryl Capital Management LP, Beryl Capital Partners II LP, and David A. Witkin reported 0 shares and 0% beneficial ownership of Enzo Biochem common stock (CUSIP 294100102) as of 09/30/2025.

The filing affirms the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control. Item 5 indicates ownership of five percent or less of the class. All voting and dispositive powers are listed as 0.